FUNDING- Office of Research on Women's Health (ORWH)
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (PA-24-247), (PA-24-248)
Due date: January 5, 2025
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications(PA-24-245), (PA-24-246)
Due date: January 5, 2025
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (PAR-25-213), (PAR-25-223)
First available due date: January 7, 2025
NOSI: Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)(NOT-OD-24-179)
First available due date: January 22, 2025
Notice of ORWH participation in NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (PAR-23-183)
Application due date: February 26, 2025
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) (PAR-24-238), (PAR-24-239)
First available due date: June 2, 2025
NOSI: Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements (NOT-OD-24-145) Submission dates follow the NIH standard due dates
Expiration date: December 14, 2026
Find out more information about how to apply in this video and by referencing the presentation slides.
NOSI: Autoimmune Inner Ear Disease (Clinical Trials Not Allowed)
(NOT-DC-25-003)
Submission dates follow the NIH standard due dates
Expiration date: October 17, 2027
Notice of Special Interest (NOSI): Women's Health Research (NOT-OD-24-079) Submission dates vary by awarding NIH Institute or Center Contacts
ORWH has released a new NOSI to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause). The NOSI will serve as a dedicated, one-stop shop that centralizes all existing funding opportunities across each of NIH's 27 institutes that align with women's health research interests.
Notice of NIGMS Interest in Research to Address Biological Sex Differences(NOT-GM-25-003)
Please direct all inquiries to a relevant NIGMS Program Officer
Visit ORWH's full list of sponsored funding opportunities and notices. We encourage you to explore the websites of the many ICs across NIH to stay up to date on the latest grants and funding information. You can also visit the NIH Grants & Funding website and subscribe to the NIH Guide.